Gainers
- Virpax Pharmaceuticals VRPX shares rose 18.7% to $0.29 during Thursday's after-market session. The market value of their outstanding shares is at $3.3 million.
- Heart Test Laboratories HSCS stock moved upwards by 9.02% to $0.17. The company's market cap stands at $8.3 million.
- Delcath Systems DCTH shares moved upwards by 6.83% to $3.44. The market value of their outstanding shares is at $75.8 million.
- Allarity Therapeutics ALLR stock increased by 6.59% to $0.58. The company's market cap stands at $2.8 million.
- Palisade Bio PALI stock increased by 6.33% to $0.63. The market value of their outstanding shares is at $5.7 million.
- Dermata Therapeutics DRMA shares rose 6.04% to $0.7. The market value of their outstanding shares is at $2.4 million.
Losers
- Aadi Bioscience AADI stock decreased by 59.8% to $2.15 during Thursday's after-market session. The company's market cap stands at $52.7 million.
- Aileron Therapeutics ALRN shares decreased by 16.58% to $4.48. The company's market cap stands at $21.8 million.
- Ontrak OTRK stock fell 10.92% to $0.4. The company's market cap stands at $11.0 million.
- Acurx Pharmaceuticals ACXP stock fell 9.23% to $3.05. The company's market cap stands at $41.9 million.
- Telesis Bio TBIO shares declined by 7.85% to $0.38. The market value of their outstanding shares is at $11.2 million.
- RenovoRx RNXT stock fell 7.45% to $0.89. The market value of their outstanding shares is at $9.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ACXPAcurx Pharmaceuticals Inc
$0.80015.48%
ALLRAllarity Therapeutics Inc
$1.01-1.97%
ALRNAileron Therapeutics Inc
$1.75-0.57%
DCTHDelcath Systems Inc
$11.01-1.52%
DRMADermata Therapeutics Inc
$1.148.57%
HSCSHeartSciences Inc
$3.522.92%
OTRKOntrak Inc
$1.44-1.37%
PALIPalisade Bio Inc
$1.75-2.77%
RNXTRenovoRx Inc
$1.204.35%
TBIOTelesis Bio Inc
--%
VRPXVirpax Pharmaceuticals Inc
$0.353813.5%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in